{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:30:38Z","timestamp":1787614238704,"version":"build-2736575974"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Aim:<\/jats:bold> Accumulating evidence suggests that MELD-XI score holds the ability to predict the prognosis of congestive heart failure. However, most of the evidence is based on the end-stage heart failure population; thus, we aim to explore the association between the MELD-XI score and the prognosis in heart failure with preserved ejection fraction (HFpEF).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A total of 30,096 patients hospitalized for HFpEF in Fujian Provincial Hospital between January 1, 2014 and July 17, 2020 with available measures of creatinine and liver function were enrolled. The primary endpoint was 60-day in-hospital all-cause mortality. Secondary endpoints were 60-day in-hospital cardiovascular mortality and 30-day rehospitalization for heart failure.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 222 patients died within 60 days after admission, among which 75 deaths were considered cardiogenic. And 73 patients were readmitted for heart failure within 30 days after discharge. Generally, patients with an elevated MELD-XI score tended to have more comorbidities, higher NYHA class, and higher inflammatory biomarkers levels. Meanwhile, the MELD-XI score was positively correlated with NT-pro BNP, left atrial diameter, E\/e' and negatively correlated with LVEF. After adjusting for conventional risk factors, the MELD-XI score was independently associated with 60-day in-hospital all-cause mortality [hazard ratio(HR) = 1.052, 95% confidential interval (CI) 1.022\u20131.083, <jats:italic>P<\/jats:italic> = 0.001], 60-day in-hospital cardiovascular mortality (HR = 1.064, 95% CI 1.013\u20131.118, <jats:italic>P<\/jats:italic> = 0.014), and 30-day readmission for heart failure (HR = 1.061, 95% CI 1.015\u20131.108, <jats:italic>P<\/jats:italic> = 0.009). Furthermore, the MELD-XI score added an incremental discriminatory capacity to risk stratification models developed based on this cohort.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The MELD-XI score was associated with short-term adverse events and provided additional discriminatory capacity to risk stratification models in patients hospitalized for HFpEF.<\/jats:p>","DOI":"10.3389\/fcvm.2021.650191","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T04:25:46Z","timestamp":1621916746000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["MELD-XI Score Is Associated With Short-Term Adverse Events in Patients With Heart Failure With Preserved Ejection"],"prefix":"10.3389","volume":"8","author":[{"given":"Sunying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manqing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation","volume":"18","author":"Ter Maaten","year":"2016","journal-title":"Eur J Heart Fail."},{"key":"B4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ehf2.12222","article-title":"Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction","volume":"5","author":"Yoshihisa","year":"2018","journal-title":"ESC Heart Fail."},{"key":"B5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.amjcard.2019.11.006","article-title":"Effect of Serum albumin levels in patients with heart failure with preserved ejection fraction (from the TOPCAT Trial)","volume":"125","author":"Prenner","year":"2020","journal-title":"Am J Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat Rev Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/eurjhf\/hfs007","article-title":"EVEREST trial investigators, Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial","volume":"14","author":"Ambrosy","year":"2012","journal-title":"Eur J Heart Fail."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1161\/CIRCULATIONAHA.115.020894","article-title":"Gastrointestinal and liver issues in heart failure","volume":"133","author":"Sundaram","year":"2016","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.healun.2012.02.008","article-title":"Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction","volume":"31","author":"Chokshi","year":"2012","journal-title":"J Heart Lung Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.healun.2012.11.026","article-title":"Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation","volume":"32","author":"Kato","year":"2013","journal-title":"J Heart Lung Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.jacc.2012.12.056","article-title":"Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction","volume":"61","author":"Kim","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/ejhf.644","article-title":"Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure","volume":"18","author":"Biegus","year":"2016","journal-title":"Eur J Heart Fail."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.jacc.2015.08.878","article-title":"Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF","volume":"66","author":"Simpson","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1053\/ajkd.2001.20748","article-title":"National kidney foundation K\/DOQI clinical practice guidelines for nutrition in chronic renal failure","volume":"37","author":"Kopple","year":"2001","journal-title":"Am J Kidney Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","article-title":"Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program","volume":"11","author":"Allen","year":"2009","journal-title":"Eur J Heart Fail."},{"key":"B17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jamacardio.2020.5592","article-title":"Association of visit-to-visit variability in kidney function and serum electrolyte indexes with risk of adverse clinical outcomes among patients with heart failure with preserved ejection fraction","volume":"6","author":"Segar","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/heartjnl-2012-303347","article-title":"MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery","volume":"99","author":"Assenza","year":"2013","journal-title":"Heart."},{"key":"B19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ijcard.2014.08.052","article-title":"Prognostic impact of renal and hepatic dysfunction based on the MELD-XI score in patients with acute heart failure","volume":"176","author":"Inohara","year":"2014","journal-title":"Int J Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e100618","DOI":"10.1371\/journal.pone.0100618","article-title":"Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure","volume":"9","author":"Abe","year":"2014","journal-title":"PLoS ONE."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/eurheartj\/ehp032","article-title":"The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure","volume":"30","author":"Vazquez","year":"2009","journal-title":"Eur Heart J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s11739-019-02033-3","article-title":"Liver histopathological findings in advanced heart failure: a reappraisal of cardiac cirrhosis concept","volume":"14","author":"Durante-Mangoni","year":"2019","journal-title":"Intern Emerg Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients","volume":"16","author":"van Deursen","year":"2010","journal-title":"J Card Fail."},{"key":"B25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijcard.2011.07.056","article-title":"Analysis of liver metabolism in a rat model of heart failure","volume":"161","author":"Kato","year":"2012","journal-title":"Int J Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low myocardial protein kinase G activity in heart failure with preserved ejection fraction","volume":"126","author":"van Heerebeek","year":"2012","journal-title":"Circulation."}],"updated-by":[{"DOI":"10.3389\/fcvm.2021.717166","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000}}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.650191\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T11:47:49Z","timestamp":1624621669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.650191\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":26,"alternative-id":["10.3389\/fcvm.2021.650191"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.650191","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fcvm.2021.717166","asserted-by":"object"}]},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"article-number":"650191"}}